Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation.

Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation.

<h4>Introduction</h4>Remdesivir and Dexamethasone represent the cornerstone of therapy for critically ill patients with acute hypoxemic respiratory failure caused by Coronavirus Disease 2019 (COVID-19). However, clinical efficacy and safety of concomitant administration of Remdesivir and...

Full description

Bibliographic Details
Main Authors: Gennaro De Pascale, Salvatore Lucio Cutuli, Simone Carelli, Rikardo Xhemalaj, Tommaso Rosà, Giuseppe Bello, Joel Vargas, Melania Cesarano, Luca Montini, Eloisa Sofia Tanzarella, Gabriele Pintaudi, Mariangela Di Muro, Domenico Luca Grieco, Massimo Antonelli
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0267038

Internet

https://doi.org/10.1371/journal.pone.0267038

Similar Items